Skip to content
value.today
Conversion Labs, Inc. logo

Conversion Labs, Inc.

Conversion Labs, Inc. is listed today as LifeMD, Inc.: market value, financials and filings are on its company page.

Funding rounds

0 counted as startup funding, 2 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Conversion Labs, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2020$16 MPrivate placement after listing$10 to $50 million

Conversion Labs, Inc.: Private sale, Nov 2020

Investors in this round

23 investors had bought by the notice of Nov 20, 2020: 23 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$16 M of $16 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$960,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Juan Manuel Pineiro Dagnery · Executive Officer · Chief Financial Officer
  • Justin Schreiber · Executive Officer, Director · Chief Executive Officer
  • Nicholas Manuel Alvarez · Executive Officer · Chief Acquisition Officer
  • Stefan Manuel Galluppi · Executive Officer, Director · Chief Operating Officer and Chief Technology Officer
  • Bertrand Manuel Velge · Director
  • Dr. Joseph V DiTrolio · Director
  • Eleanor C. Mariano · Director
  • Happy Manuel Walters · Director
  • John Manuel Strawn · Director
  • Roberto V Simon · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • BTIG, LLC (CRD 122225) · broker-dealer BTIG, LLC (CRD 122225) · San Francisco, CaliforniaSold in all US states

Signed by Justin Schreiber, Chief Executive Officer. Source: SEC Form D, newest notice filed Nov 20, 2020. Read the notice at the SEC.

equity, optionsSEC
Aug 2020$4 MPrivate placement after listing$2 to $10 million

Conversion Labs, Inc.: Private sale, Aug 2020

Investors in this round

1 investor had bought by the notice of Sep 8, 2020: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Juan Manuel Pineiro Dagnery · Executive Officer · Chief Financial Officer
  • Justin Schreiber · Executive Officer, Director · Chief Executive Officer
  • Nicholas Manuel Alvarez · Executive Officer · Chief Acquisition Officer
  • Stefan Manuel Galluppi · Executive Officer, Director · Chief Operating Officer and Chief Technology Officer
  • Anthony Manuel Bruzzese · Director
  • Bertrand Manuel Velge · Director
  • Dr. Joseph V. DiTrolio · Director
  • Happy Manuel Walters · Director
  • John Manuel Strawn · Director
  • Michael Manuel Borenstein · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Justin Schreiber, Chief Executive Officer. Source: SEC Form D, newest notice filed Sep 8, 2020. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • As the listed company LifeMD, Inc., its revenue in fiscal 2025 came from these business segments: Telehealth $194.06 million (100%), Telehealth Subscription Revenue $113.27 million (58%).

    Annual report (SEC XBRL) · Dec 2025

  • Conversion Labs, Inc. chose not to state its revenue in its newest notice of a funding round (Nov 2020).

    SEC Form D · Nov 2020

  • The industry group it chose in its notices: Other.

    SEC Form D · Nov 2020

Products and services#

No products or services of Conversion Labs, Inc. are on record.

Investors#

No investor of Conversion Labs, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete.

Largest shareholders today

Institutions holding LifeMD, Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Conversion Labs, Inc.
NameRoleNamed in
Juan Manuel Pineiro DagneryChief Financial OfficerNov 2020
Justin SchreiberChief Executive OfficerNov 2020
Nicholas Manuel AlvarezChief Acquisition OfficerNov 2020
Stefan Manuel GalluppiChief Operating Officer and Chief Technology OfficerNov 2020
Bertrand Manuel VelgeDirectorNov 2020
Dr. Joseph V DiTrolioDirectorNov 2020
Eleanor C. MarianoDirectorNov 2020
Happy Manuel WaltersDirectorNov 2020
John Manuel StrawnDirectorNov 2020
Justin SchreiberChief Executive OfficerNov 2020
Roberto V SimonDirectorNov 2020
Stefan Manuel GalluppiChief Operating Officer and Chief Technology OfficerNov 2020
Anthony Manuel BruzzeseDirectorSep 2020
Dr. Joseph V. DiTrolioDirectorSep 2020
Michael Manuel BorensteinDirectorSep 2020

Went public since 2014. Its SEC number is that of a company listed on a stock exchange.